Completed OBSERVATIONAL NCT02837354

The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage? (CAA)

Sponsor: Fondation Hôpital Saint-Joseph

Conditions CADASIL

Updated 7 times since 2017 Last updated: Jul 18, 2016 Started: Jun 30, 2014 Primary completion: Nov 30, 2015 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02837354, this observational or N/A phase trial focuses on CADASIL and remains completed. Sponsored by Fondation Hôpital Saint-Joseph, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — Sep 2023 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondation Hôpital Saint-Joseph

Data source: Fondation Hôpital Saint-Joseph

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France